¼¼°èÀÇ °¡»ó Áø·á ½ÃÀå
Virtual Visits
»óǰÄÚµå : 1795210
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 300 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,183,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,550,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

°¡»ó Áø·á ¼¼°è ½ÃÀåÀº 2030³â±îÁö 1,023¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 261¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â °¡»ó Áø·á ¼¼°è ½ÃÀåÀº 2024-2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 25.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 1,023¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¾Ë·¹¸£±â¡¤¸é¿ªÇÐÀº CAGR 28.7%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 315¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±ä±Þ ÀÇ·á(Urgent Care) ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 21.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 71¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 34.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ °¡»ó Áø·á ½ÃÀåÀº 2024³â¿¡ 71¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 255¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 34.1%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 20.3%¿Í 23.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 21.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ °¡»ó Áø·á ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

°¡»ó Áø·á´Â Çö´ë ÀÇ·á ¼­ºñ½º¿¡¼­ ȯÀÚ¿Í ÀÇ·áÁøÀÇ °ü°è¸¦ ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

°¡»ó Áø·á´Â ±âÁ¸ÀÇ Á¢±Ù À庮À» ¾ø¾Ö°í µðÁöÅÐ Ç÷§ÆûÀ» ÅëÇØ ¿ø°ÝÁø·á¸¦ Á¦°øÇÔÀ¸·Î½á ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ °ü°è ¹æ½ÄÀ» ȹ±âÀûÀ¸·Î º¯È­½Ã۰í ÀÖ½À´Ï´Ù. È­»óȸÀÇ, ¾ÈÀüÇÑ ¸Þ½Ã¡, ½Ç½Ã°£ µ¥ÀÌÅÍ °øÀ¯¸¦ ÅëÇØ °¡»ó Áø·á´Â ´ë¸é Áø·á¿¡ ´ëÇÑ È¿À²ÀûÀÌ°í Æí¸®ÇÏ¸ç ¾ÈÀüÇÑ ´ë¸é Áø·áÀÇ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. °¡»ó Áø·á´Â Ãʱ⿡´Â °øÁߺ¸°Ç ºñ»ó»çÅ¿¡¼­ Á¢ÃËÀ» ÃÖ¼ÒÈ­ÇÏ°í °¨¿° À§ÇèÀ» ÁÙÀ̱â À§ÇØ Ã¤ÅõǾúÁö¸¸, ÀÌÈÄ Àü ¼¼°è ¸¹Àº ÀÇ·á ½Ã½ºÅÛ¿¡¼­ ÁÖ·ù·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. ÀÌ·¯ÇÑ ¹æ¹® Áø·á¸¦ ÅëÇØ ȯÀÚ´Â Áý¿¡¼­ ÀÇ»ç, Ä¡·á»ç, Àü¹®°¡¿Í »ó´ãÇÒ ¼ö ÀÖÀ¸¸ç, À̵¿, Áø·á¼Ò ´ë±â, Á÷Àå ÈÞ¹«ÀÇ Çʿ伺À» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÆíÀǼºÀº Àü¹®ÀÇ¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦ÇÑÀûÀÎ Áö¹æÀ̳ª ÀÇ·á¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ªÀÇ È¯Àڵ鿡°Ô ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. °¡»ó Áø·á´Â ¶ÇÇÑ ´õ ºó¹øÇÑ Ã¼Å©ÀÎ, ¸¸¼ºÁúȯ ¸ð´ÏÅ͸µ, ÈÄ¼Ó Áø·á°¡ °¡´ÉÇÏ¿© Áø·áÀÇ ¿¬¼Ó¼ºÀ» ³ô¿©ÁÝ´Ï´Ù. ÀÇ·áÁøÀº ½ºÄÉÁÙ¸µÀÇ À¯¿¬¼º, ¿¹¾à ¿ë·® Áõ°¡, º¸´Ù È¿À²ÀûÀÎ ¿öÅ©ÇÃ·Î¿ì °ü¸®ÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¡»ó Áø·á´Â µðÁöÅÐ °Ç°­ ÃßÀû±â, ÀüÀÚ Ã³¹æÀü, ±³À° ÀÚ·á¿Í °°Àº µµ±¸¸¦ ÅëÇÕÇÏ¿© ȯÀÚ°¡ ÀÚ½ÅÀÇ °Ç°­À» ÅëÁ¦ÇÒ ¼ö ÀÖµµ·ÏÇÔÀ¸·Î½á ´õ °­·ÂÇÑ È¯ÀÚ Âü¿©¸¦ ÃËÁøÇÕ´Ï´Ù. ¸¹Àº Ç÷§ÆûÀÇ Á¢±Ù¼º°ú »ç¿ëÀÚ Ä£È­ÀûÀÎ µðÀÚÀÎÀº ¿ø°ÝÀǷḦ ´õ¿í Æ÷°ýÀûÀ¸·Î ¸¸µé¾î ³ëÀÎ, °Åµ¿ÀÌ ºÒÆíÇÑ »ç¶÷, °¡Á·ÀÇ °Ç°­ Ã¥ÀÓÀ» °ü¸®ÇÏ´Â °£º´Àο¡°Ô ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ȯÀÚ¿Í ÀÓ»óÀǰ¡ µðÁöÅÐ ÇコÄɾî¿ÍÀÇ »óÈ£ÀÛ¿ë¿¡ Àͼ÷ÇØÁü¿¡ µû¶ó, °¡»ó Áø·á´Â ÇコÄɾ ´ëÇÑ Á¢±Ù¼º, °³ÀÎÈ­, ´ëÀÀ·ÂÀ» ³ôÀÌ´Â Çõ½ÅÀû ÈûÀ¸·Î ÀÔÁõµÇ°í ÀÖ½À´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß¿¡¼­ °¡»ó Áø·áÀÇ ºÎ»ó°ú ½Å·Ú¼ºÀ» µÞ¹ÞħÇÏ´Â ±â¼úÀº ¹«¾ùÀϱî?

ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ °¡»ó Áø·áÀÇ Áö¼ÓÀûÀÎ Áõ°¡´Â ´õ¿í °íµµ·Î ÅëÇÕµÇ°í ±¤¹üÀ§ÇÏ°Ô Ã¤Åõǰí ÀÖ´Â µðÁöÅÐ ±â¼úÀÇ °­·ÂÇÑ Á¶ÇÕ¿¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. °íÇØ»óµµ È­»óȸÀÇ Ç÷§ÆûÀº ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ ½Ç½Ã°£ »óÈ£ ÀÛ¿ëÀ» Á¦°øÇÏ¿© ´ë¸é Ä¿¹Â´ÏÄÉÀ̼ÇÀÇ ´µ¾Ó½º¸¦ º¸´Ù ¸íÈ®Çϰí Áï°¢ÀûÀ¸·Î ÀçÇöÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ °Ç°­ ¾ÖÇø®ÄÉÀ̼ǰú ȯÀÚ Æ÷ÅÐÀº °¡»ó ¿¹¾à ¿¹¾à, º´·Â Á¦Ãâ, Áø·á ÈÄ Áö½Ã»çÇ×À» ¹ÞÀ» ¼ö ÀÖ´Â ÁÖ¿ä °ÔÀÌÆ®¿þÀÌ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀüÀÚ ÀÇ·á ±â·Ï(EHR) ÅëÇÕÀ» ÅëÇØ °¡»ó Áø·á Áß¿¡µµ ȯÀÚ µ¥ÀÌÅÍ¿¡ ¿øÈ°ÇÏ°Ô Á¢±ÙÇÒ ¼ö ÀÖÀ¸¸ç, ÀÇ·áÁøÀº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸®°í ½Ç½Ã°£À¸·Î ±â·ÏÀ» ¾÷µ¥ÀÌÆ®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀΰøÁö´ÉÀº ȯÀÚ ºÐ·ù, °ü¸® ¿öÅ©Ç÷οì ÀÚµ¿È­, Áõ»ó °Ë»ç±â¸¦ ÅëÇÑ ¿¹ºñ Áø´ÜÀ» Áö¿øÇÏ´Â µ¥ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ±â±â ¹× ¿ø°Ý ¸ð´ÏÅ͸µ µµ±¸´Â »ýü °Ç°­ µ¥ÀÌÅ͸¦ ÀÇ·áÁø¿¡°Ô Á÷Á¢ Àü¼ÛÇÏ¿© °íÇ÷¾Ð, ´ç´¢º´, ½ÉÀåÁúȯ µîÀÇ º´Å °ü¸®¿¡ °¡»ó Ä¡·á¸¦ °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ ¾Ïȣȭ, ´Ù´Ü°è ÀÎÁõ, º¸¾È ¼­¹ö¸¦ ÅëÇØ °¡»ó ÀÎÅÍ·¢¼ÇÀº ÀÇ·á °³ÀÎ Á¤º¸ º¸È£ ±ÔÁ¤À» ÁؼöÇϰí ȯÀÚÀÇ ºñ¹ÐÀ» º¸È£ÇÕ´Ï´Ù. À½¼º ÀÎ½Ä ¹× ÀÚ¿¬¾î ó¸® ±â¼úÀº Áø·á ±â·Ï°ú Á¤È®ÇÑ Çʻ縦 Áö¿øÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ÀÎÇÁ¶ó´Â ´Ù¾çÇÑ Áö¿ª°ú ½Ã°£´ë¿¡ °ÉÃÄ ¼­ºñ½º¿¡ ´ëÇÑ È®À强°ú ¾ÈÁ¤ÀûÀÎ ¾×¼¼½º¸¦ º¸ÀåÇÕ´Ï´Ù. »óÈ£ ¿î¿ë¼ºÀÌ Çâ»óµÊ¿¡ µû¶ó °¡»ó Áø·á Ç÷§ÆûÀº ¾à±¹ ½Ã½ºÅÛ, °Ë»ç½Ç, ¿µ»ó ¼¾ÅÍ¿Í ´õ ½±°Ô ¿¬°áµÉ ¼ö ÀÖ°Ô µÇ¾î Á¾ÇÕÀûÀÎ µðÁöÅÐ Áø·á ÁֱⰡ ¿Ï¼ºµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº °¡»ó Áø·áÀÇ Ç°Áú°ú ½Å·Ú¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, Àå±âÀûÀ¸·Î ´Ù¾çÇÑ ÇコÄÉ¾î ¼­ºñ½º¿¡ È¿°úÀûÀÎ ¼Ö·ç¼ÇÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

ȯÀÚ, ÀÇ·á Á¦°øÀÚ, ÁöºÒÀÚ°¡ °¡»ó Áø·áÀÇ µµÀÔÀ» ÁöÁöÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

°¡»ó Áø·áÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ȯÀÚ, ÀÇ·á ¼­ºñ½º Á¦°øÀÚ, ÁöºÒÀÚ »çÀÌ¿¡ µðÁöÅÐ Áø·á°¡ Ä¡·á °á°ú¸¦ °³¼±ÇÏ°í ºñ¿ëÀ» Àý°¨Çϸç Á¢±Ù¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ´Ù´Â ÀνÄÀÌ °øÀ¯µÈ °á°úÀÔ´Ï´Ù. ȯÀÚµéÀº °¡»ó Áø·á°¡ Á¦°øÇÏ´Â ÆíÀǼº, À̵¿ ½Ã°£ ´ÜÃà, ÀÇ·á Á¶¾ð¿¡ ´ëÇÑ ºü¸¥ Á¢±Ù¼ºÀ» ³ôÀÌ Æò°¡Çϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀ̳ª °Åµ¿ÀÌ ºÒÆíÇÑ È¯Àڵ鿡°Ô Áý¿¡¼­ Àü¹®ÀÇ¿Í »ó´ãÇÒ ¼ö ÀÖ´Ù´Â °ÍÀº Å« º¯È­ÀÔ´Ï´Ù. ¶ÇÇÑ, µðÁöÅп¡ Àͼ÷ÇÑ ÀþÀº ÃþÀº °¡»ó Áø·á¸¦ ÇÏÀÌÅ×Å© ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ ÀÚ¿¬½º·¯¿î ¿¬Àå¼±»ó¿¡¼­ ¹Þ¾ÆµéÀ̰í ÀÖÀ¸¸ç, ÀÏ»óÀûÀ¸·Î ÀÌ¿ëÇÏ´Â ´Ù¸¥ µðÁöÅÐ ¼­ºñ½º¿Í µ¿µîÇÑ ¼öÁØÀÇ Æí¸®ÇÔÀ» ÇコÄɾ ±â´ëÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â °¡»ó Áø·á°¡ Áø·á ¹üÀ§¸¦ ³ÐÈ÷°í, ³ë¼îÀ²À» ³·Ã߸ç, ¿¹¾à È¿À²À» Çâ»ó½Ãų ¼ö ÀÖ´Ù´Â °ÍÀ» ÀνÄÇϰí ÀÖ½À´Ï´Ù. °¡»ó ÀǷḦ Áø·á¿¡ ÅëÇÕÇÔÀ¸·Î½á ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â ¾÷¹«·®À» ´õ Àß °ü¸®Çϰí, ¹°¸®Àû ÀÎÇÁ¶ó¿Í °ü·ÃµÈ Á¦¹Ý ºñ¿ëÀ» Àý°¨Çϸç, ȯÀÚ¿ÍÀÇ ±ä¹ÐÇÑ ÈÄ¼Ó Á¶Ä¡¸¦ À¯ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. ÁöºÒÀÚ¿Í º¸Çè»ç´Â ºÒÇÊ¿äÇÑ ÀÀ±Þ½Ç ¹æ¹®, º´¿ø ÀçÀÔ¿ø, Àå±âÀûÀÎ Ä¡·á ºñ¿ëÀ» ÁÙÀ̱â À§ÇÑ ºñ¿ë Àý°¨ ¹æ¾ÈÀ¸·Î °¡»ó Áø·á¸¦ º¸°í ÀÖ½À´Ï´Ù. ÇöÀç ¸¹Àº ±â¾÷µéÀÌ ¿ø°ÝÀÇ·á ¼­ºñ½º¸¦ º¸Çè ÇýÅÃÀÇ ´ë»óÀ¸·Î »ï°í, ȯÀÚ Áß½ÉÀÇ Áø·á¿Í °æÁ¦Àû Àμ¾Æ¼ºê¸¦ ÀÏÄ¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¡»ó Ç÷§ÆûÀÇ ºÐ¼®À» ÅëÇØ ÀÌÇØ°ü°èÀÚµéÀº Áø·á ÆÐÅÏ, ¼øÀÀµµ, Áý´Ü °Ç°­ µ¿Çâ¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ¸ðµç °ü°èÀÚ°¡ °¡»ó Áø·á¿¡ Àͼ÷ÇØÁö°í Àͼ÷ÇØÁö¸é¼­ ±× ÀÌÁ¡ÀÌ Á¡Á¡ ´õ ºÐ¸íÇØÁö°í ÀÖ½À´Ï´Ù. °¡»ó Áø·á¸¦ ÀϽÃÀûÀÎ ÇØ°áÃ¥ÀÌ ¾Æ´Ñ ȯÀÚ Ä¡·áÀÇ ±âº» ºÎºÐÀ¸·Î ÀÚ¸®¸Å±èÇÔÀ¸·Î½á ÀÇ·á ¼­ºñ½º Á¦°øÀÇ ¹®È­Àû º¯È­¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Àü ¼¼°è °¡»ó Áø·áÀÇ ¼ºÀåÀ» °¡¼ÓÈ­ÇÏ´Â ½ÃÀå ¿ø¸®¿Í Á¤Ã¥ ÀüȯÀº ¹«¾ùÀϱî?

°¡»ó Áø·á ½ÃÀåÀÇ ¼ºÀåÀº ¼¼°è ÇコÄÉ¾î Æ®·»µå, Á¤Ã¥ °³Çõ, ¼ÒºñÀÚ ±â´ëÄ¡ º¯È­ µîÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. °¡Àå Å« ¿øµ¿·Â Áß Çϳª´Â ÀÇ·á ½Ã½ºÅÛ¿¡ ´ëÇÑ ¸¸¼ºÀûÀÎ ºÎ´ãÀ̸ç, Á¤ºÎ¿Í ÀÇ·á ±â°üÀº È®Àå °¡´ÉÇÏ°í ºñ¿ë È¿À²ÀûÀÎ Ä¡·á ¸ðµ¨À» ¿øÇϰí ÀÖ½À´Ï´Ù. °¡»ó Áø·á´Â Áö¸®Àû, »çȸ°æÁ¦Àû ¶Ç´Â ¹°·ùÀû À庮¿¡ Á÷¸éÇÑ »ç¶÷µéÀÇ Áø·á Á¢±Ù¼ºÀ» È®´ëÇÏ´Â ÇÑÆí, °ú¹ÐÈ­µÈ Áø·á¼Ò¿Í º´¿ø¿¡ ´ëÇÑ ¾Ð·ÂÀ» ¿ÏÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇØ ¸¹Àº Á¤ºÎ°¡ ¿ø°ÝÀÇ·á ģȭÀûÀÎ ±ÔÁ¦¿Í Á¤Ã¥À» µµÀÔÇϰí, »óȯ Á¤Ã¥À» È®´ëÇϸç, °¡»ó Áø·á Á¦°øÀ» Áö¿øÇÏ´Â µðÁöÅÐ ÀÎÇÁ¶ó¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¤Ã¥ ÀüȯÀ¸·Î ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ °¡»ó Áø·á ¼­ºñ½º¸¦ µµÀÔÇϰí È®´ëÇÒ ¼ö ÀÖ´Â ¹ýÀû, ÀçÁ¤Àû ±â¹ÝÀÌ ¸¶·ÃµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÇコÄɾ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, ȯÀÚµéÀº ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿¡°Ô ´õ ³ôÀº ÆíÀǼº, Åõ¸í¼º, ½Å¼Ó¼ºÀ» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. COVID-19 ÆÒµ¥¹ÍÀº ÀÇ·á ½Ã½ºÅÛ¿¡ ¿ø°ÝÁø·á ¼Ö·ç¼ÇÀ» ½Å¼ÓÇÏ°Ô µµÀÔÇϵµ·Ï °­¿äÇÔÀ¸·Î½á äÅÃÀ» Å©°Ô °¡¼ÓÈ­ÇßÀ¸¸ç, À§±â »óȲ¿¡¼­ µµÀÔµÈ ¸¹Àº Àӽà Á¶Ä¡°¡ ÀÌÈÄ ¿µ±¸ÀûÀÎ Á¶Ä¡·Î ¹Ù²î¾ú½À´Ï´Ù. ±â¼ú ±â¾÷, º¥Ã³ ijÇÇÅ», ÀÇ·á ½Ã½ºÅÛÀÇ ÅõÀÚ·Î ±â¼ú Çõ½Å°ú °æÀïÀÌ ÃËÁøµÇ¾î ´Ù¾çÇÑ Àü¹® ºÐ¾ß¿Í ȯÀÚ Æ¯¼º¿¡ ¸Â´Â ´Ù¾çÇÑ Ç÷§ÆûÀÌ Åº»ýÇß½À´Ï´Ù. ÇÑÆí, Á¤½Å°Ç°­ ¼­ºñ½º, ÇǺΰú, ¼Ò¾Æ°ú, ±âŸ ºÐ¾ß¿ÍÀÇ ÅëÇÕÀÌ ÁøÇàµÇ¸é¼­ °¡»ó Áø·áÀÇ ¹üÀ§¿Í ¸Å·ÂÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. µðÁöÅÐ ¹®ÇØ·ÂÀÌ Çâ»óµÇ°í 5G ¿¬°áÀÌ È®»êµÊ¿¡ µû¶ó °¡»ó Áø·á ½ÃÀåÀº ´õ¿í È®´ëµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, µµ½Ã¿Í ³óÃÌÀ» ¸··ÐÇϰí ÀÇ·á ¼­ºñ½º Á¦°øÀÇ ¹Ì·¡¸¦ À籸¼ºÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

ºÎ¹®

¼­ºñ½º À¯Çü(¾Ë·¹¸£±â¡¤¸é¿ª, ±ä±Þ ÀÇ·á, ¿¹¹æ ÀÇ·á, ¸¸¼º ÀÇ·á °ü¸®, Çൿ ÀÇ·á, ±âŸ ¼­ºñ½º À¯Çü), ¿¬·ÉÃþ(15¼¼ ¹Ì¸¸, 15-30¼¼, 31-45¼¼, 46-65¼¼, 65¼¼ ÀÌ»ó)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Virtual Visits Market to Reach US$102.3 Billion by 2030

The global market for Virtual Visits estimated at US$26.1 Billion in the year 2024, is expected to reach US$102.3 Billion by 2030, growing at a CAGR of 25.6% over the analysis period 2024-2030. Allergy & Immunology, one of the segments analyzed in the report, is expected to record a 28.7% CAGR and reach US$31.5 Billion by the end of the analysis period. Growth in the Urgent Care segment is estimated at 21.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.1 Billion While China is Forecast to Grow at 34.1% CAGR

The Virtual Visits market in the U.S. is estimated at US$7.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$25.5 Billion by the year 2030 trailing a CAGR of 34.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 20.3% and 23.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 21.6% CAGR.

Global Virtual Visits Market - Key Trends & Drivers Summarized

How Are Virtual Visits Transforming Patient-Provider Relationships in Modern Healthcare?

Virtual visits have dramatically reshaped how patients and healthcare providers interact by removing traditional barriers to access and delivering care remotely through digital platforms. Enabled by video conferencing, secure messaging, and real-time data sharing, virtual visits provide an efficient, convenient, and safe alternative to in-person consultations. Initially embraced during public health emergencies to minimize contact and reduce transmission risk, virtual visits have since become a mainstream option in many healthcare systems worldwide. These visits allow patients to consult with doctors, therapists, and specialists from the comfort of their homes, reducing the need to travel, wait in clinics, or take time off work. This convenience is especially valuable for patients in rural or underserved areas where specialist access is limited. Virtual visits also enhance the continuity of care by enabling more frequent check-ins, chronic disease monitoring, and follow-up consultations. Providers benefit from greater scheduling flexibility, increased appointment capacity, and more efficient workflow management. Furthermore, virtual visits foster stronger patient engagement by integrating tools such as digital health trackers, e-prescriptions, and educational resources that empower individuals to take control of their health. The ease of access and user-friendly design of many platforms has made telehealth more inclusive, serving elderly populations, individuals with mobility challenges, and caregivers managing family health responsibilities. As both patients and clinicians become more comfortable with digital healthcare interactions, virtual visits are proving to be a transformative force in making healthcare more accessible, personalized, and responsive.

What Technologies Are Powering the Rise and Reliability of Virtual Visits in Healthcare?

The continued rise of virtual visits in healthcare is driven by a robust combination of digital technologies that are becoming more advanced, integrated, and widely adopted. High-definition video conferencing platforms provide real-time interaction between patients and healthcare providers, replicating the nuances of face-to-face communication with improved clarity and responsiveness. Mobile health applications and patient portals serve as the primary gateways for scheduling virtual appointments, submitting medical histories, and receiving post-consultation instructions. Electronic health records (EHR) integration enables seamless access to patient data during virtual visits, allowing providers to make informed decisions and update records in real time. Artificial intelligence is being used to triage patients, automate administrative workflows, and even support preliminary diagnosis through symptom checkers. Wearable devices and remote monitoring tools transmit vital health data directly to providers, making virtual care effective for managing conditions such as hypertension, diabetes, and cardiac disorders. Data encryption, multi-factor authentication, and secure servers ensure that virtual interactions are compliant with healthcare privacy regulations and protect patient confidentiality. Voice recognition and natural language processing technologies assist in documenting visits and transcribing consultations accurately. Cloud infrastructure ensures scalability and reliable access to services across different geographies and time zones. As interoperability improves, virtual visit platforms are beginning to connect more easily with pharmacy systems, laboratories, and imaging centers, completing a comprehensive digital care cycle. These technological advancements are not only enhancing the quality and reliability of virtual visits but also making them a viable long-term solution for a broad range of healthcare services.

Why Are Patients, Providers, and Payers Increasingly Supporting Virtual Visit Adoption?

The growing adoption of virtual visits is the result of a shared recognition among patients, healthcare providers, and payers that digital care can improve outcomes, reduce costs, and increase accessibility. Patients appreciate the convenience, reduced travel time, and faster access to medical advice that virtual visits offer. For those with chronic conditions or mobility limitations, the ability to consult specialists without leaving home is transformative. Younger, digitally savvy populations have also embraced virtual visits as a natural extension of their tech-driven lifestyles, expecting healthcare to match the convenience of other digital services they use daily. Healthcare providers are recognizing that virtual visits can increase their reach, reduce no-show rates, and improve appointment efficiency. By integrating virtual care into their practices, providers can better manage workloads, reduce overhead costs associated with physical infrastructure, and maintain closer follow-up with their patients. Payers and insurance companies see virtual visits as a cost-saving measure that reduces unnecessary emergency room visits, hospital readmissions, and long-term treatment costs. Many are now including telehealth services as a reimbursable benefit, aligning financial incentives with patient-centric care. Additionally, the use of analytics from virtual platforms provides stakeholders with insights into care patterns, adherence rates, and population health trends. As all parties grow more familiar and comfortable with virtual visits, their benefits are becoming increasingly evident. This collective support is driving a cultural shift in healthcare delivery, positioning virtual visits not as a temporary solution but as a fundamental part of the patient care continuum.

What Market Forces and Policy Shifts Are Accelerating the Growth of Virtual Visits Worldwide?

The growth in the virtual visits market is driven by a confluence of global healthcare trends, policy reforms, and changing consumer expectations. One of the most significant drivers is the chronic strain on healthcare systems, which is prompting governments and institutions to seek scalable and cost-effective models of care. Virtual visits help to alleviate pressure on overcrowded clinics and hospitals while expanding access to care for populations that face geographic, socioeconomic, or logistical barriers. In response to this need, many governments have introduced telehealth-friendly regulations, broadened reimbursement policies, and invested in digital infrastructure to support virtual care delivery. These policy shifts have provided the legal and financial foundation for healthcare providers to adopt and expand virtual visit services. Additionally, rising healthcare consumerism is influencing demand, as patients expect greater convenience, transparency, and responsiveness from their providers. The COVID-19 pandemic significantly accelerated adoption by forcing healthcare systems to implement remote care solutions rapidly, and many of the temporary measures introduced during the crisis have since become permanent fixtures. Investments from technology companies, venture capitalists, and health systems have fueled innovation and competition, resulting in a wide range of platforms tailored to different specialties and patient demographics. Meanwhile, increasing integration with mental health services, dermatology, pediatrics, and other disciplines is broadening the scope and appeal of virtual visits. As digital literacy continues to rise and 5G connectivity becomes more widespread, the market for virtual visits is expected to expand further, reshaping the future of healthcare delivery across urban and rural landscapes alike.

SCOPE OF STUDY:

The report analyzes the Virtual Visits market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (Allergy & Immunology, Urgent Care, Preventive Care, Chronic Care Management, Behavioral Health, Other Service Types); Age Group (Below 15 Years, 15 - 30 Years, 31 - 45 Years, 46 - 65 Years, Above 65 Years)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â